Randy Milby - Jan 14, 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Stock symbol
THAR
Transactions as of
Jan 14, 2022
Transactions value $
$40,455
Form type
4
Date filed
1/20/2022, 08:25 AM
Previous filing
Jan 20, 2022
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THAR Common Stock Conversion of derivative security $47.8K +14.9K +0.69% $3.20* 2.17M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $74.3K +23.2K +1.07% $3.20* 2.2M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $1.3K +406 +0.02% $3.20* 2.2M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $74.2K +23.2K +1.06% $3.20* 2.22M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $52.9K +16.5K +0.74% $3.20* 2.24M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $50.6K +15.8K +0.71% $3.20* 2.25M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $21.1K +6.59K +0.29% $3.20* 2.26M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $52.6K +16.5K +0.73% $3.20* 2.27M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $69.3K +21.7K +0.95% $3.20* 2.3M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $42K +13.1K +0.57% $3.20* 2.31M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $78.5K +24.5K +1.06% $3.20* 2.33M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $62.8K +19.6K +0.84% $3.20* 2.35M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $71.4K +22.3K +0.95% $3.20* 2.38M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $78.2K +24.4K +1.03% $3.20* 2.4M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $57.2K +17.9K +0.74% $3.20* 2.42M Jan 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THAR Convertible Note Conversion of derivative security -$45K 0 Jan 14, 2022 Common stock 14.9K $3.20 Direct F1
transaction THAR Convertible Note Conversion of derivative security -$70K 0 Jan 14, 2022 Common stock 23.2K $3.20 Direct F2
transaction THAR Convertible Note Conversion of derivative security -$1.23K 0 Jan 14, 2022 Common stock 406 $3.20 Direct F3
transaction THAR Convertible Note Conversion of derivative security -$70K 0 Jan 14, 2022 Common stock 23.2K $3.20 Direct F4
transaction THAR Convertible Note Conversion of derivative security -$50K 0 Jan 14, 2022 Common stock 16.5K $3.20 Direct F5
transaction THAR Convertible Note Conversion of derivative security -$48K 0 Jan 14, 2022 Common stock 15.8K $3.20 Direct F6
transaction THAR Convertible Note Conversion of derivative security -$20K 0 Jan 14, 2022 Common stock 6.59K $3.20 Direct F7
transaction THAR Convertible Note Conversion of derivative security -$50K 0 Jan 14, 2022 Common stock 16.5K $3.20 Direct F8
transaction THAR Convertible Note Conversion of derivative security -$66K 0 Jan 14, 2022 Common stock 21.7K $3.20 Direct F9
transaction THAR Convertible Note Conversion of derivative security -$40K 0 Jan 14, 2022 Common stock 13.1K $3.20 Direct F10
transaction THAR Convertible Note Conversion of derivative security -$75K 0 Jan 14, 2022 Common stock 24.5K $3.20 Direct F11
transaction THAR Convertible Note Conversion of derivative security -$60K 0 Jan 14, 2022 Common stock 19.6K $3.20 Direct F12
transaction THAR Convertible Note Conversion of derivative security -$68.5K 0 Jan 14, 2022 Common stock 22.3K $3.20 Direct F13
transaction THAR Convertible Note Conversion of derivative security -$75K 0 Jan 14, 2022 Common stock 24.4K $3.20 Direct F14
transaction THAR Convertible Note Conversion of derivative security -$55K 0 Jan 14, 2022 Common stock 17.9K $3.20 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 14, 2020, the Registrant issued the Reporting Person a $45,000 note which matures on the earlier of (i) October 14, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F2 On October 27, 2020, the Registrant issued the Reporting Person notes in the aggregate principal amount of $70,000. The notes mature on the earlier of (i) October 27, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the notes together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F3 On November 1, 2020, the Registrant issued the Reporting Person a $1,225.37 note which matures on the earlier of (i) November 1, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F4 On November 2, 2020, the Registrant issued the Reporting Person a $70,000 note which matures on the earlier of (i) November 2, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F5 On November 18, 2020, the Registrant issued the Reporting Person a $50,000 note which matures on the earlier of (i) November 18, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F6 On December 9, 2020, the Registrant issued the Reporting Person a $48,000 note which matures on the earlier of (i) December 9, 2023 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F7 On December 16, 2020, the Registrant issued the Reporting Person a $20,000 note which matures on the earlier of (i) December 16, 2023 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F8 On December 23, 2020, the Registrant issued the Reporting Person a $50,000 note which matures on the earlier of (i) December 23, 2023 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F9 On January 15, 2021, the Registrant issued the Reporting Person a $66,000 note which matures on the earlier of (i) January 15, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F10 On January 22, 2021, the Registrant issued the Reporting Person a $40,000 note which matures on the earlier of (i) January 22, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F11 On February 4, 2021, the Registrant issued the Reporting Person a $75,000 note which matures on the earlier of (i) February 4, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F12 On February 12, 2021, the Registrant issued the Reporting Person a $60,000 note which matures on the earlier of (i) February 12, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F13 On March 3, 2021, the Registrant issued the Reporting Person notes in the aggregate principal amount of $68,476.50. The notes mature on the earlier of (i) March 3, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the notes together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F14 On March 12, 2021, the Registrant issued the Reporting Person a $75,000 note which matures on the earlier of (i) March 12, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F15 On March 29, 2021, the Registrant issued the Reporting Person a $55,000 note which matures on the earlier of (i) March 29, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.

Remarks:

This is the second of the Form 4s.